JO
ALGS icon

John Overdeck’s Aligos Therapeutics ALGS Stock Holding History

John Overdeck’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,093
Closed -$172K – 5036
2026
Q1 		$172K Sell
23,093
-57,556
-71% -$437K ﹤0.01% 4309
2025
Q4 		$752K Buy
80,649
+41,654
+107% +$393K ﹤0.01% 3098
2025
Q3 		$382K Buy
38,995
+26,922
+223% +$246K ﹤0.01% 3110
2025
Q2 		$87K Buy
12,073
+1,023
+9% +$6.12K ﹤0.01% 3012
2025
Q1 		$91.2K Buy
+11,050
New +$242K ﹤0.01% 2972
2024
Q3 		– Sell
-748
Closed -$6.55K – 3098
2024
Q2 		$6.55K Buy
748
+3
+0.4% +$53 ﹤0.01% 2971
2024
Q1 		$18.3K Hold
745
– – ﹤0.01% 2934
2023
Q4 		$12.4K Sell
745
-172
-19% -$2.96K ﹤0.01% 3075
2023
Q3 		$17.1K Sell
917
-250
-21% -$5.54K ﹤0.01% 2876
2023
Q2 		$28.3K Sell
1,167
-1,107
-49% -$29.7K ﹤0.01% 2883
2023
Q1 		$49.7K Sell
2,274
-1,343
-37% -$51.3K ﹤0.01% 2755
2022
Q4 		$86.2K Sell
3,617
-1,360
-27% -$34.3K ﹤0.01% 2527
2022
Q3 		$137K Sell
4,977
-2,839
-36% -$94.3K ﹤0.01% 2188
2022
Q2 		$236K Sell
7,816
-292
-4% -$9.92K ﹤0.01% 2110
2022
Q1 		$436K Buy
8,108
+5,413
+201% +$433K ﹤0.01% 2084
2021
Q4 		$800K Sell
2,695
-900
-25% -$328K ﹤0.01% 2766
2021
Q3 		$1.39M Buy
+3,595
New +$1.42M ﹤0.01% 2312

Other funds holding ALGS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

John Overdeck's ALGS Position: Q2 2026 in Review

John Overdeck sold out of Aligos Therapeutics (ALGS) in Q2 2026, closing a stake of 23,093 shares — an estimated $172K sold.

John Overdeck first reported a position in ALGS in Q3 2021 and held it in 17 quarters. The position peaked at $1.39M in Q3 2021. 31 funds tracked by Wall St. Rank hold ALGS as of Q2 2026.

  • John Overdeck reported no remaining Aligos Therapeutics position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 23,093 Aligos Therapeutics shares in Q2 2026, an estimated $172K.
  • John Overdeck first reported a position in Aligos Therapeutics in Q3 2021 and held it in 17 quarters.
  • John Overdeck's Aligos Therapeutics position peaked at $1.39M in Q3 2021.
  • 31 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.